selected scholarly activity
-
conferences
- A population-based comparison of the cardiovascular protective effects of hydrochlorothiazide and chlorthalidone. Circulation. 459-459. 2007
- Pharmacist Medication Assessments in a Surgical Preadmission Clinic. JAMA Internal Medicine. 1034-1034. 2007
- Implementation and a randomized controlled evaluation of pharmacist medication assessments in a surgical pre-admission clinic.. Pharmacotherapy. 1462-1462. 2005
-
journal articles
- The quality of pharmacist-led community warfarin management across 2 provinces in Canada: A cross-sectional observational study. Canadian Pharmacists Journal. 157:77-83. 2024
- Variation in bleeding risk estimates among online calculators. Canadian Family Physician. 68:e127-e135. 2022
- Managing hypertension in primary care.. Canadian Family Physician. 65:725-729. 2019
- Simplifying QT prolongation for busy clinicians.. Canadian Family Physician. 65:268-270. 2019
- Using a course pilot in the development of an online problem-based learning (PBL) therapeutics course in a post-professional PharmD program. Currents in Pharmacy Teaching and Learning. 10:231-234. 2018
- Evaluation of a Unique Interprofessional Education Program Involving Medical and Pharmacy Students. American Journal of Pharmaceutical Education. 81:6140-6140. 2017
- Evaluation of a Unique Interprofessional Education Program Involving Medical and Pharmacy Students. American Journal of Pharmaceutical Education. 81:80-86. 2017
- Different perspective on ASA use. Canadian Family Physician. 62:28-30. 2016
- Different perspective on ASA use.. Canadian Family Physician. 62:30-31. 2016
- Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.. Canadian Family Physician. 60:e535-e540. 2014
- Chlorthalidone Versus Hydrochlorothiazide for the Treatment of Hypertension in Older Adults. ACP journal club. 158:447-447. 2013
- Possible enhancement of the effect of warfarin secondary to oral prednisone therapy. Canadian Journal of Hospital Pharmacy. 61:264-266. 2008
- Pseudoephedrine-Induced Toxic Epidermal Necrolysis. JAMA dermatology. 141:907-908. 2005
- Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy. American Heart Journal. 149:e19-e19. 2005
- Letter to the editor. American Heart Journal. 149:e21-e21. 2005
- Low-Molecular-Weight Heparin for Anticoagulation During Continuous Venovenous Hemofiltration—Reply. Archives of Internal Medicine. 163:981-981. 2003
- Low-molecular-weight heparin for anticougulation during continuous venovenous hemofiltration - Reply. JAMA Internal Medicine. 163:981-981. 2003
- Acute Profound Thrombocytopenia Associated with Eptifibatide Therapy. Pharmacotherapy. 23:374-379. 2003
- Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin?. JAMA Internal Medicine. 162:2605-2605. 2002